CIK 0001727196
- Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823750435
- Phone
- +1 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-27 | Reed Joshua Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2024-06-27 | Peng Katie Director | Grant or award | +4,500 | 31,325 | ||
| 2024-06-27 | Peng Katie Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2024-06-27 | Gilman Michael Director | Grant or award | +13,500 | 13,500 | ||
| 2024-06-27 | Gilman Michael Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2024-06-27 | FLIER JEFFREY S. Director | Grant or award | +13,500 | 22,513 | ||
| 2024-06-27 | FLIER JEFFREY S. Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2024-06-27 | Brudnick Richard Director | Grant or award | +13,500 | 13,500 | ||
| 2024-06-27 | Brudnick Richard Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2024-06-27 | AKKARAJU SRINIVAS Director | Grant or award | +13,500 | 13,500 | ||
| 2024-06-27 | AKKARAJU SRINIVAS Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2024-06-27 | Hallal David Director | Grant or award | +13,500 | 304,095 | ||
| 2024-06-27 | Hallal David Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2024-06-17 | Qatanani Mo CHIEF SCIENTIFIC OFFICER | Sale | −2,315 | $8.99 | $21K | 144,704 |
| 2024-06-17 | Parlavecchio Caryn CHRO | Sale | −4,305 | $8.98 | $39K | 153,439 |
| 2024-06-17 | Myles Edward H COO & CFO | Sale | −9,458 | $8.98 | $85K | 201,518 |
| 2024-06-17 | Ho Junlin GENERAL COUNSEL | Sale | −4,695 | $8.98 | $42K | 204,076 |
| 2024-05-09 | Nashat Amir Director | Other disposition | −472,394 | 1,650,953 | ||
| 2024-05-09 | Nashat Amir Director | Other acquisition | +98,257 | 98,257 | ||
| 2024-05-09 | Nashat Amir Director | Other disposition | −98,257 | 0 |
Page 15 of 22 · 422 trades